Recombinant protein expression in Nicotiana

Area of Science:

• Biotechnology
• Molecular Biology
• Plant Sciences

Background:

• Recombinant protein pharmaceuticals are crucial for treating chronic diseases and for vaccines.
• Current manufacturing relies heavily on mammalian cell cultures, facing capacity limitations and high capital costs.
• There is a growing need for alternative, cost-effective, and scalable protein production systems.

Purpose of the Study:

• To evaluate plant expression systems, specifically Nicotiana leaf tissues, as a viable alternative for recombinant protein manufacturing.
• To highlight the advancements in plant-based expression technologies, including transient expression systems.
• To address the challenges and solutions in purifying recombinant proteins from plant sources.

Main Methods:

• Utilizing transient expression systems derived from recombinant plant viral vectors for rapid screening and scale-up.
• Employing extraction methods from Nicotiana leaf tissues, including secreted protein fractions and total protein extracts.
• Implementing purification strategies to overcome contamination from photosynthetic components.

Main Results:

• Plant expression systems, particularly in Nicotiana species, have demonstrated significant technological advancements.
• Transient expression systems facilitate efficient screening, optimization, and scale-up of protein production.
• Effective purification strategies exist to remove plant-specific contaminants like photosynthetic elements.

Conclusions:

• Technologies for safe, efficient, and scalable recombinant protein manufacture in Nicotiana leaf tissues are mature.
• Several products derived from these systems have undergone Phase I clinical trials.
• A robust pipeline of recombinant vaccines, microbicides, and therapeutic proteins is anticipated from this technology.